+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 9Years - 12Years
All Genders
ID06718842

Walking Program for Children Aged 9 to 12 with Phenylketonuria and Non-Alcoholic Fatty Liver Disease to Improve Liver Enzymes

Led by Cairo University · Updated on 2024-12-05

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Phenylketonuria PKU is an inherited disorder that raises phenylalanine levels in the blood and is linked with metabolic complications such as non-alcoholic fatty liver disease. Researchers are studying children with PKU and fatty liver disease to understand how a walking program might affect their liver health. This study is interventional and involves children aged 9 to 12 years who have PKU and fatty liver disease. Participants will be randomly assigned to one of two groups. Group I will take part in a daily online supervised walking program for eight weeks. Group II will be a waitlisted control group that does not perform the walking program during this period. The program is designed to evaluate the response of liver enzymes after the intervention. During the study, researchers will assess liver enzymes including alanine transaminase, aspartate transaminase, gamma-glutamyl transferase, and alkaline phosphatase, as well as triglycerides and body mass index after eight weeks. The study includes safety monitoring and data collection throughout the eight-week period. Total participation duration aligns with the length of the walking program and follow-up assessments.

CONDITIONS

Brief Title

Walking Program in Fatty Liver Children With Phenylketonuria

Research Team

A

Ali Isamil, Lecturer

S

shimaaa bondok, PHD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here